Biotechnology

Genetic Engineering Synthetic Biology Gene Editing Medical Technology mRNA Technology Drug Development Genetic Modification Nanotechnology Pharmaceuticals Vaccine Technology

Illumina Launches Billion Cell Atlas to Train AI in Drug Discovery

The release marks BioInsight’s first commercial offering, signaling Illumina’s push to sell proprietary datasets beyond sequencing instruments.

ISS Microgravity Reshapes Phage–Bacteria Coevolution, Revealing Mutations With Potential Against Resistant E. coli

Nuclera Extends Series C to $87 Million to Accelerate Full-Format Antibody Workflows

Aktis Oncology Soars 24% in Nasdaq Debut After $318 Million IPO

Scientists Report Trace DNA From Disputed Drawing That Could Tie to Leonardo da Vinci

Aurora Therapeutics Launches to Scale Bespoke Gene Editing for PKU

CRISPR Cas12a3 Found to Cut tRNA Tails, Halting Protein Synthesis

Variant Bio Launches Agentic AI Genomics Platform as It Secures Boehringer Ingelheim Kidney-Disease Deal

Scientists Build First Breathing Lung-on-a-Chip From a Single Donor’s Cells

New iGluSnFR4 Sensor Lets Scientists See Neurons’ Incoming Signals in Living Brains

Vertex Projects Casgevy Sales Above $100 Million in 2025 as CRISPR Therapeutics Waits for Payoff

Engineered Womb Lining Supports Human Embryo Implantation in Lab, Revealing Early Pregnancy Signals

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

Northwestern and Stanford Build Cell-Free Pathway to Turn CO2-Derived Formate Into Valuable Chemicals

4D Nucleome Project Publishes Most Detailed 3D Maps of the Human Genome

Scripps Nanoparticle Vaccines Elicit Cross-Filovirus Antibodies in Mice

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Bryan Johnson Sets 2039 'Immortality' Goal, Commissions Organ Clones for AI-Driven Testing

T Cell Receptor Switches From Closed to Open in Native Membrane, Rewriting Activation Model

Inito Raises $29 Million to Advance AI-Designed Antibodies for At-Home Diagnostics